The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

The US Food and Drug Administration says it plans to use artificial intelligence to help speed the approval of new drugs and medical devices.

More than 1.7 million window air conditioners are being recalled due to a risk for mold growth, which can lead to serious health problems.

Cessation of public water fluoridation would increase tooth decay and health system costs in the United States.